Skip to main content

Chetan Bettegowda

NIH Rank #2132
  • Program Leader
  • R01 Holder
  • Multi-Institutional
  • Early Career
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 6649548Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Internal Medicine
  • Radiology
  • Neurosurgery

NIH Funding · FY2024

Linked Award Amount
$3.4M
Full award amounts, FY2024
Award Records
6
Records listing this PI
Award-Linked Rank
#2,132
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Chetan Bettegowda. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Chetan Bettegowda as a PI. Multi-PI records show the full award amount for context.

  • 5U01CA271867-03U01
    Validation of Biomarkers for predicting Barrett's esophagus that will or will not: i) progress towards cancer, or ii) recur after ablation
    $996.9K
    award amount
  • 5R01FD007271-04R01
    Phase IIA Trial of Dichloroacetate for Glioblastoma Multiforme, IND137007, 09172019
    $669K
    award amount
  • 5R01CA276221-02R01
    Integrating circulating tumor DNA assay and protein-based MRI to accurately monitor glioma therapy
    $635.8K
    award amount
  • 5U01CA230691-07U01
    Multi-analyte Approach for Earlier Detection of Cancers in Non Plasma Biofluids
    $415.6K
    award amount
  • 5R37CA230400-07R37
    Interrogating malignant gliomas using released tumor DNA in cerebrospinal fluid
    $355.9K
    award amount
  • 1R42NS135834-01R42
    Multi-omic CSF Assay for the Diagnosis of Brain Cancers
    $303.8K
    award amount

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Johns Hopkins University
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #2132
  6. 2024
    Entered Top 25% Nationally
    Ranked #2132
  7. 2025
    $5M Cumulative Funding
  8. 2025
    Multi-Institutional Research
    Awards at 4 institutions
  9. 2025
    R01 Grant Holder
  10. 2025
    Program/Center Grant Leader